首页 | 本学科首页   官方微博 | 高级检索  
     

异甘草酸镁对慢性乙型肝炎患者肝纤维化指标的影响
引用本文:崔鹤松,陈宁. 异甘草酸镁对慢性乙型肝炎患者肝纤维化指标的影响[J]. 世界临床药物, 2008, 29(11): 670-673
作者姓名:崔鹤松  陈宁
作者单位:吉林省延边大学医院感染科
摘    要:目的 探讨异甘草酸镁对慢性乙型肝炎患者肝纤维化指标的影响.方法 选取60例慢性乙型肝炎住院患者,随机分为两组.对照组(n=24)接受一般保肝药物治疗,治疗组(n=36)在对照组基础上加用异甘草酸镁治疗,疗程均为1月,观察各组治疗前后透明质酸(HA)、层黏蛋白(LN)、Ⅳ型胶原(ⅣC)、转化生长因子-β1(TGF-β1)含量的变化情况.结果 与治疗前相比,治疗组HA、LN、ⅣC及TGF-β1含量治疗后均显著下降(P<0.05,),而对照组上述指标无明显下降(P>0.05).与对照组相比,治疗组各指标下降显著(P<0.05).结论 异甘草酸镁具有降低慢性乙型肝炎患者肝纤维化指标的作用.

关 键 词:异甘草酸镁  乙型肝炎  慢性  肝纤维化

The effect of magnesium isoglycyrrhizinate on indicators of hepatic fibrosis in patients with chronic type B hepatitis
CUI He-Song,CHEN Ning. The effect of magnesium isoglycyrrhizinate on indicators of hepatic fibrosis in patients with chronic type B hepatitis[J]. WORLD CLINICAL DRUGS, 2008, 29(11): 670-673
Authors:CUI He-Song  CHEN Ning
Affiliation:CUI He-Song,CHEN Ning(Department of Infectious Diseases,Yanbian University Hospital,Yanji 133000,China)
Abstract:Objective To evaluate the effect of magnesium isoglycyrrhizinate on indicators of hepatic fibrosis in patients with chronic type B hepatitis.Methods 60 in-patients with chronic type B hepatitis were randomly divided into two groups.Patients in control group(n = 24) were administered conventional liver protectants while patients in treatment group(n = 36)were added magnesium isoglycyrrhizinate on the basis of control group.The treatment course were both one month.The levels of hyaluronic acid(HA), laminin(LN...
Keywords:magnesium isoglycyrrhizinate  type B hepatitis  chronic  hepatic fibrosis  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号